Stay updated on BGB324 in Recurrent Glioblastoma Surgery Clinical Trial

Sign up to get notified when there's something new on the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.9%
    Check dated 2025-07-04T03:54:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.7%
    Check dated 2025-06-19T19:24:26.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:05:48.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:51:39.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:54:49.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed information about a phase I trial for the AXL inhibitor BGB324 in treating recurrent glioblastoma, while adding new identifiers and collaborators related to the study.
    Difference
    44%
    Check dated 2025-04-16T02:00:41.000Z thumbnail image

Stay in the know with updates to BGB324 in Recurrent Glioblastoma Surgery Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page.